Evaluation of the Sensititre YeastOne and Etest in Comparison with CLSI M38-A2 for Antifungal Susceptibility Testing of Three Azoles, Amphotericin B, Caspofungin, and Anidulafungin, against <i>Aspergillus</i><i>fumigatus</i> and Other Species, Using New Clinical Breakpoints and Epidemiological Cutoff Values

Evaluation of the Sensititre YeastOne and Etest in Comparison with CLSI M38-A2 for Antifungal Susceptibility Testing of Three Azoles, Amphotericin B, Caspofungin, and Anidulafungin, against <i>Aspergillus</i><i>fumigatus</i> and Other Species, Using New Clinical Breakpoints and Epidemiological Cutoff Values

Aspergillosis is an invasive fungal disease associated with high mortality. Antifungal susceptibility testing (AFST) is receiving increasing consideration for managing patients, as well as for surveilling emerging drug resistance, despite having time-consuming and technically complex reference metho...

Full description

Bibliographic Details
Main Authors: Marcia S. C. Melhem, Vivian C. Coelho, Claudia A. Fonseca, Lidiane de Oliveira, Lucas X. Bonfietti, Maria. W. Szeszs, Marcello M. C. Magri, Francine S. Dorneles, Hideaki Taguchi, Daniel V. S. Moreira, Adriana L. Motta, Marjorie V. Batista, Katsuhiko Kamei, Maria A. Shikanai-Yasuda
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Pharmaceutics
Subjects:
gradient diffusion assays
<i>Aspergillus fumigatus</i>
Etest
CLSI
Sensititre YeastOne
azole antifungals
Online Access:https://www.mdpi.com/1999-4923/14/10/2161

Internet

https://www.mdpi.com/1999-4923/14/10/2161

Similar Items